Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations.
Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer.
Drug repositioning for anti-tuberculosis drugs: an in silico polypharmacology approach.
Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatment.
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling for transcriptomic analysis.
Automatic Identification of Analogue Series from Large Compound Data Sets: Methods and Applications.
Diagnostic biomarkers and potential drug targets for coronary artery disease as revealed by systematic analysis of lncRNA characteristics.
Do initial concentration and activated sludge seasonality affect pharmaceutical biotransformation rate constants?
The Complex Structure of the Pharmacological Drug-Disease Network.